| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $477.5M | — | +14.6% |
| Cost of Revenue | $340.7M | — | +11.3% |
| Gross Profit | $136.8M | — | +23.8% |
| R&D Expense | $8.1M | — | -11.0% |
| SG&A Expense | $51.0M | — | +11.1% |
| Operating Income | $76.3M | — | +17.6% |
| Pre-tax Income | $61.2M | — | +7.7% |
| Income Tax | $12.8M | — | +5.8% |
| Net Income | $48.4M | — | +8.3% |
| EPS (Basic) | $0.59 | — | +9.3% |
| EPS (Diluted) | $0.59 | — | +9.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $209.6M | -11.3% | +14.3% |
| Accounts Receivable | $303.7M | -5.1% | +7.5% |
| Inventory | $298.7M | +5.8% | +10.3% |
| Current Assets | $911.1M | +2.1% | +16.3% |
| Total Assets | $1.84B | +36.4% | +50.0% |
| Current Liabilities | $360.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $38.1M | — | +32.8% |
| Capital Expenditures | $12.6M | — | +1.6% |
| Investing Cash Flow | -$467.9M | — | -3673.4% |
| Financing Cash Flow | $402.6M | — | +2349.2% |
| Free Cash Flow | $25.5M | — | +56.4% |
| +2.5% |
| Long-term Debt | $1.00B | +75.4% | +69.8% |
| Total Liabilities | $1.44B | +47.9% | +49.4% |
| Stockholders' Equity | $403.5M | +6.6% | +52.1% |